Silver Nanoparticles with Mebeverine in IBS Treatment: DFT Analysis, Spasmolytic, and Anti-Inflammatory Effects
Authors:
- Mihaela StoyanovaMSMihaela Stoyanova
- Miglena MilushevaMiglena Milusheva
- Vera GledachevaVera Gledacheva
- Mina TodorovaMTMina Todorova
- Nikoleta KirchevaNikoleta Kircheva
- Silvia AngelovaSilvia Angelova
- Iliyana StefanovaIliyana Stefanova
- Mina PenchevaMPMina Pencheva
- Bela VasilevaBVBela Vasileva
- Kamelia Hristova-PanushevaKamelia Hristova-Panusheva
- Natalia KrastevaNKNatalia Krasteva
- George MiloshevGMGeorge Miloshev
Open Access
- 24 April 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (5) , 561
Abstract
Background/Objectives: Mebeverine hydrochloride (MBH) is an antispasmodic agent used to regulate bowel movements and relax intestinal smooth muscle, but its application is limited by specific side effects; therefore, this study investigates the effects of previously synthesized MBH-loaded silver nanoparticles (AgNPs) on smooth muscle contractile activity and their anti-inflammatory potential as an alternative delivery system. Methods: The interactions of AgNPs with cholinergic inhibitors, selective antagonists, Ca2+ blockers, and key neurotransmitters were analyzed. In vitro, albumin denaturation suppression and ex vivo assays evaluated the anti-inflammatory effects of AgNPs-MBH, validated using a DFT in silico approach. To comprehensively assess the systemic impact and IBS treatment potential of AgNPs-MBH, we also examined in vitro their antimicrobial activity and hepatic cell responses, as the liver is a key organ in evaluating the overall safety and efficacy of nanoparticles. Additionally, the drug-release capabilities of Ag NPs were established. Results: Our findings indicate that AgNPs with MBH do not affect blocked cholinergic receptors, but their effects are more pronounced and distinct in amplitude and character than MBH. MBH-loaded AgNPs showed a lower anti-inflammatory effect than MBH but were still better than diclofenac. They also affected hepatic cell morphology and proliferation, suggesting potential for enhanced therapeutic efficacy. Drug-loaded AgNPs are considered not bactericidal. Conclusions: Based on our results, drug-loaded AgNPs might be a promising medication delivery system for MBH and a useful treatment option for IBS. Future in vivo and preclinical experiments will contribute to the establishment of drug-loaded AgNPs in IBS treatment.Keywords
This publication has 86 references indexed in Scilit:
- Synergistic Cytotoxic Effects of Doxorubicin Loaded Silver, Gold and Zinc Oxide Nanoparticles in HepG2 Liver Cancer CellsBioNanoScience, 2024
- Antibacterial Activity of Green Synthesized Silver Nanoparticles Using Lawsonia inermis Against Common Pathogens from Urinary Tract InfectionApplied Biochemistry and Biotechnology, 2023
- Green approach for the fabrication of silver-oxidized cellulose nanocomposite with antibacterial propertiesCellulose, 2020
- Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold NanoparticlesJournal of Cluster Science, 2019
- Preparation of carboxy-methyl cellulose-capped nanosilver particles and their antimicrobial evaluation by an automated deviceApplied Nanoscience, 2018
- Development and validation of a web-based questionnaire to identify environmental risk factors for inflammatory bowel disease: the Groningen IBD Environmental Questionnaire (GIEQ)Journal of Gastroenterology, 2018
- Synthesis, Characterisation and DFT Studies of Stigmasterol Mediated Silver Nanoparticles and Their Anticancer ActivityJournal of Inorganic and Organometallic Polymers and Materials, 2017
- Microneedles for Drug Delivery via the Gastrointestinal TractJournal of Pharmaceutical Sciences, 2015
- Mebeverine‐Loaded Electrospun Nanofibers: Physicochemical Characterization and Dissolution StudiesJournal of Pharmaceutical Sciences, 2014
- Cholinergic excitation of smooth muscles: Multiple signaling pathways linking M2 and M3 muscarinic receptors to cationic channelsNeurophysiology, 2004